These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SV2 is the protein receptor for botulinum neurotoxin A. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER. Science; 2006 Apr 28; 312(5773):592-6. PubMed ID: 16543415 [Abstract] [Full Text] [Related]
7. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. Peng L, Tepp WH, Johnson EA, Dong M. PLoS Pathog; 2011 Mar 28; 7(3):e1002008. PubMed ID: 21483489 [Abstract] [Full Text] [Related]
8. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Biochemistry; 2009 Jun 23; 48(24):5631-41. PubMed ID: 19476346 [Abstract] [Full Text] [Related]
9. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Rummel A. Curr Top Microbiol Immunol; 2013 Jun 23; 364():61-90. PubMed ID: 23239349 [Abstract] [Full Text] [Related]
10. Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry. Joensuu M, Syed P, Saber SH, Lanoue V, Wallis TP, Rae J, Blum A, Gormal RS, Small C, Sanders S, Jiang A, Mahrhold S, Krez N, Cousin MA, Cooper-White R, Cooper-White JJ, Collins BM, Parton RG, Balistreri G, Rummel A, Meunier FA. EMBO J; 2023 Jul 03; 42(13):e112095. PubMed ID: 37226896 [Abstract] [Full Text] [Related]
11. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding. Gustafsson R, Zhang S, Masuyer G, Dong M, Stenmark P. Toxins (Basel); 2018 Apr 12; 10(4):. PubMed ID: 29649119 [Abstract] [Full Text] [Related]
12. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, Stirnimann CU, McMillan D, Ceska T, Lebon F, Jaussi R, Steinmetz MO, Schertler GF, Hoogenraad CC, Capitani G, Kammerer RA. Nature; 2014 Jan 02; 505(7481):108-11. PubMed ID: 24240280 [Abstract] [Full Text] [Related]
15. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. Rummel A, Häfner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, Beermann S, Karnath T, Bigalke H, Binz T. J Neurochem; 2009 Sep 02; 110(6):1942-54. PubMed ID: 19650874 [Abstract] [Full Text] [Related]
17. Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A. Yamagata A, Ito K, Suzuki T, Dohmae N, Terada T, Shirouzu M. Nat Commun; 2024 Apr 18; 15(1):3027. PubMed ID: 38637505 [Abstract] [Full Text] [Related]
18. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. Yao G, Zhang S, Mahrhold S, Lam KH, Stern D, Bagramyan K, Perry K, Kalkum M, Rummel A, Dong M, Jin R. Nat Struct Mol Biol; 2016 Jul 18; 23(7):656-62. PubMed ID: 27294781 [Abstract] [Full Text] [Related]
19. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Baldwin MR, Barbieri JT. Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420 [Abstract] [Full Text] [Related]
20. Three players in the 'toxic affair' between botulinum neurotoxin type A and neurons. Rossetto O, Pirazzini M, Montecucco C. Trends Neurosci; 2023 Sep 20; 46(9):695-697. PubMed ID: 37385877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]